These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10582480)
1. [Evolution of ovarian stimulation in in vitro fertilization]. Delbaere A; Devreker F; Hannes M; Koenig I; Holoye A; Englert Y Rev Med Brux; 1999 Oct; 20(5):A446-52. PubMed ID: 10582480 [TBL] [Abstract][Full Text] [Related]
2. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961 [TBL] [Abstract][Full Text] [Related]
4. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations. Loutradis D; Elsheikh A; Kallianidis K; Drakakis P; Stefanidis K; Milingos S; Michalas S Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266 [TBL] [Abstract][Full Text] [Related]
5. Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? Engel JB; Ludwig M; Felberbaum R; Albano C; Devroey P; Diedrich K Hum Reprod; 2002 Aug; 17(8):2022-6. PubMed ID: 12151431 [TBL] [Abstract][Full Text] [Related]
6. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966 [TBL] [Abstract][Full Text] [Related]
7. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040 [TBL] [Abstract][Full Text] [Related]
8. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer. Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845 [TBL] [Abstract][Full Text] [Related]
9. [GnRH analog protocols revisited I--advantages and doubts]. Hugues JN; Cédrin Durnerin I Contracept Fertil Sex; 1997 Jun; 25(6):445-56. PubMed ID: 9280549 [TBL] [Abstract][Full Text] [Related]
12. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989 [TBL] [Abstract][Full Text] [Related]
13. Mild stimulation in in vitro fertilization. Macklon NS; Fauser BC Ann N Y Acad Sci; 2003 Nov; 997():105-11. PubMed ID: 14644815 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques. Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565 [TBL] [Abstract][Full Text] [Related]